
*ClariPi was featured on SBS TV program!
“Secrets of Ultra-Low Dose CT Technology” -watch the full episode here!
“Secrets of Ultra-Low Dose CT Technology” -watch the full episode here!
당사는 정관 제25조에 의거, 임시주주총회를 아래와 같이 개최하오니 참석하여 주시기 바랍니다.
2025년4월11일개최한주식회사클라리파이이사회에서아래와같이제3자배 정방법으로신주발행을결의하였음을공고합니다.
당사는 상법 제 363조와 당사 정관 제25조에 의거, 정기 주주총회를 아래와 같이 개최하고자 하오니 참석하여 주시기 바랍니다.
ClariPi sets Germany as its main target market in Europe and plans to focus on expanding its market share by strengthening cooperation with various medical institutions and companies in Europe.
Accelerates Conquest of Middle Eastern Market
CEO Kim Jong-hyo said, “I am delighted to be able to share the achievements of Clarify, which has focused on improving patient safety as its top priority in technology development, with medical institutions and partners around the world through ECR 2024.”
Clarify participated in the ‘2024 Dubai International Medical Devices Exhibition’.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec feugiat nibh, non finibus eros. Nullam semper fringilla lorem, non varius nunc fermentum et. Sed eu pharetra tortor.
ClariPi and Redcon’s Agreement to Expand Supply Chain in the Asia Region